{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:12:41Z","timestamp":1793394761960,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91113-w","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T16:36:18Z","timestamp":1740414978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Synthesis and application of diazenyl sulfonamide-based schiff bases as potential BRCA2 active inhibitors against MCF-7 breast cancer cell line"],"prefix":"10.1038","volume":"15","author":[{"given":"Olia","family":"Rezaeianzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakineh","family":"Asghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Tajbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asieh","family":"Khalilpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Shityakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"91113_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/his.14786","volume":"82","author":"EA Rakha","year":"2023","unstructured":"Rakha, E. A., Tse, G. M. & Quinn, C. M. An update on the pathological classification of breast cancer. Histopathology 82, 5\u201316. https:\/\/doi.org\/10.1111\/his.14786 (2023).","journal-title":"Histopathology"},{"key":"91113_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"91113_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7\u201333. https:\/\/doi.org\/10.3322\/caac.21708 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"91113_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41698-018-0047-0","volume":"2","author":"W Chen","year":"2018","unstructured":"Chen, W., Hoffmann, A. D., Liu, H. & Liu, X. Organotropism: new insights into molecular mechanisms of breast cancer metastasis. NPJ Precis Oncol. 2, 4. https:\/\/doi.org\/10.1038\/s41698-018-0047-0 (2018).","journal-title":"NPJ Precis Oncol."},{"key":"91113_CR5","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","volume":"10","author":"U Anand","year":"2023","unstructured":"Anand, U. et al. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 10, 1367\u20131401. https:\/\/doi.org\/10.1016\/j.gendis.2022.02.007 (2023).","journal-title":"Genes Dis."},{"key":"91113_CR6","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s00520-020-05750-0","volume":"29","author":"A Kitta","year":"2021","unstructured":"Kitta, A. The silent transition from curative to palliative treatment: a qualitative study about cancer patients\u2019 perceptions of end-of-life discussions with oncologists. Support Care Cancer. 29, 2405\u20132413. https:\/\/doi.org\/10.1007\/s00520-020-05750-0 (2021).","journal-title":"Support Care Cancer"},{"key":"91113_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1200\/JCO.2015.61.6706","volume":"33","author":"LE Schnipper","year":"2015","unstructured":"Schnipper, L. E. et al. American society of clinical oncology statement: A conceptual framework to assess the value of Cancer treatment options. J. Clin. Oncol. 33, 23. https:\/\/doi.org\/10.1200\/JCO.2015.61.6706 (2015).","journal-title":"J. Clin. Oncol."},{"key":"91113_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","volume":"6","author":"L Zhong","year":"2021","unstructured":"Zhong, L. et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal. Transduct. Target. Ther. 6, 201. https:\/\/doi.org\/10.1038\/s41392-021-00572-w (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"91113_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41416-023-02502-9","volume":"130","author":"FR Weth","year":"2024","unstructured":"Weth, F. R. et al. Unlocking hidden potential: advancements, approaches, and Obstacles in repurposing drugs for cancer therapy. Br. J. Cancer. 130, 703\u2013715. https:\/\/doi.org\/10.1038\/s41416-023-02502-9 (2024).","journal-title":"Br. J. Cancer"},{"key":"91113_CR10","doi-asserted-by":"publisher","unstructured":"Apostolou, P. & Fostira, F. Hereditary breast cancer: the era of new susceptibility gene. Biomed. Res. Int. 2013 (747318). https:\/\/doi.org\/10.1155\/2013\/747318 (2013).","DOI":"10.1155\/2013\/747318"},{"key":"91113_CR11","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1200\/JCO.21.02112","volume":"40","author":"S Li","year":"2022","unstructured":"Li, S. et al. ACancer risks associated with BRCA1 and BRCA2 pathogenic variants. J. Clin. Oncol. 40, 1529\u20131541. https:\/\/doi.org\/10.1200\/JCO.21.02112 (2022).","journal-title":"J. Clin. Oncol."},{"key":"91113_CR12","doi-asserted-by":"publisher","first-page":"131824","DOI":"10.1016\/j.molstruc.2021.131824","volume":"1250","author":"AK Bishoyi","year":"2022","unstructured":"Bishoyi, A. K., Mahapatra, M., Sahoo, C. R., Paidesetty, S. K. & Padhy, R. N. Design, molecular Docking and antimicrobial assessment of newly synthesized p-cuminal-sulfonamide schiff base derivatives. J. Mol. Struct. 1250, 131824. https:\/\/doi.org\/10.1016\/j.molstruc.2021.131824 (2022).","journal-title":"J. Mol. Struct."},{"key":"91113_CR13","doi-asserted-by":"publisher","first-page":"133605","DOI":"10.1016\/j.molstruc.2022.133605","volume":"1267","author":"MA Chalkha","year":"2022","unstructured":"Chalkha, M. A. et al. Crystallographic study, biological assessment and POM\/Docking studies of pyrazoles-sulfonamide hybrids (PSH): identification of a combined antibacterial\/antiviral pharmacophore sites leading to in-silico screening the anti-Covid-19 activity. J. Mol. Struct. 1267, 133605. https:\/\/doi.org\/10.1016\/j.molstruc.2022.133605 (2022).","journal-title":"J. Mol. Struct."},{"key":"91113_CR14","doi-asserted-by":"publisher","first-page":"7664","DOI":"10.1039\/d4ra01060d","volume":"14","author":"MS Ayoup","year":"2024","unstructured":"Ayoup, M. S. et al. Novel sulfonamide derivatives as multitarget antidiabetic agents: design, synthesis, and biological evaluation. RSC Adv. 14, 7664\u20137675. https:\/\/doi.org\/10.1039\/d4ra01060d (2024).","journal-title":"RSC Adv."},{"key":"91113_CR15","doi-asserted-by":"publisher","first-page":"e202401342","DOI":"10.1002\/slct.202401342","volume":"9","author":"GM Gaddi","year":"2024","unstructured":"Gaddi, G. M. et al. Phosphatase alkaline Inhibition and antithyroid activity of acetylacetone sulfonamide derived schiff base. In vitro and In Silico studies. ChemistrySelect 9, e202401342. https:\/\/doi.org\/10.1002\/slct.202401342 (2024).","journal-title":"ChemistrySelect"},{"key":"91113_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bioorg.2018.11.033","volume":"84","author":"AAM Abdel-Aziz","year":"2019","unstructured":"Abdel-Aziz, A. A. M. et al. Synthesis and anti-inflammatory activity of sulphonamides and carboxygenase\/carbonic anhydrase inhibitory actions. Bioorg. Chem. 84, 260. https:\/\/doi.org\/10.1016\/j.bioorg.2018.11.033 (2019).","journal-title":"Bioorg. Chem."},{"key":"91113_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10593-012-0979-1","volume":"48","author":"IV Ukrainets","year":"2012","unstructured":"Ukrainets, I. V., Bereznyakova, N. L. & Heterocyclic diuretics Heterocycl. Chem. 48, 155\u2013165. https:\/\/doi.org\/10.1007\/s10593-012-0979-1 (2012).","journal-title":"Heterocycl. Chem."},{"key":"91113_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.48309\/CHEMM.2024.447205.1773","volume":"8","author":"O Rezaeianzadeh","year":"2024","unstructured":"Rezaeianzadeh, O. et al. Molecular docking, and anticancer evaluation of new Azo-Based sulfonamides against MCF-7 human breast Cancer cell line. Chem. Methodol. 8, 329\u2013350. https:\/\/doi.org\/10.48309\/CHEMM.2024.447205.1773 (2024).","journal-title":"Chem. Methodol."},{"key":"91113_CR19","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1158\/1078-0432.CCR-12-0453","volume":"18","author":"A Kirane","year":"2012","unstructured":"Kirane, A. et al. Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic Cancer. Clin. Cancer Res. 18, 5031\u20135042. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0453 (2012).","journal-title":"Clin. Cancer Res."},{"key":"91113_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.pupt.2019.03.006","volume":"56","author":"D Muccino","year":"2019","unstructured":"Muccino, D. & Green, S. Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough. Pulm Pharmacol. Ther. 56, 75\u201378. https:\/\/doi.org\/10.1016\/j.pupt.2019.03.006 (2019).","journal-title":"Pulm Pharmacol. Ther."},{"key":"91113_CR21","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41467-022-28907-3","volume":"13","author":"A Nijhuis","year":"2022","unstructured":"Nijhuis, A. et al. Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma. Nat. Commun. 13, 1380. https:\/\/doi.org\/10.1038\/s41467-022-28907-3 (2022).","journal-title":"Nat. Commun."},{"key":"91113_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/COC.0000000000000691","volume":"43","author":"PC McDonald","year":"2020","unstructured":"McDonald, P. C. et al. A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors. Am. J. Clin. Oncol. 43, 484\u2013490. https:\/\/doi.org\/10.1097\/COC.0000000000000691 (2020).","journal-title":"Am. J. Clin. Oncol."},{"key":"91113_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1586\/era.10.201","volume":"11","author":"C Palmieri","year":"2011","unstructured":"Palmieri, C., Januszewski, A., Stanway, S. & Coombes, R. C. Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer. Expert Rev. Anticancer Ther. 11, 179\u2013183. https:\/\/doi.org\/10.1586\/era.10.201 (2011).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"91113_CR24","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1021\/acs.jmedchem.0c02077","volume":"64","author":"MY Mboge","year":"2021","unstructured":"Mboge, M. Y. Inhibition of carbonic anhydrase using SLC-149: support for a Non-catalytic function of CAIX in breast Cancer. J. Med. Chem. 64, 1713\u20131724. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c02077 (2021).","journal-title":"J. Med. Chem."},{"key":"91113_CR25","doi-asserted-by":"publisher","first-page":"2300718","DOI":"10.1002\/ardp.202300718","volume":"357","author":"B Swain","year":"2024","unstructured":"Swain, B. et al. Design, synthesis, and biological evaluation of 3-benzenesulfonamide\u2010linked 3\u2010hydrazinoisatin derivatives as carbonic anhydrase inhibitors. Arch. Pharm. 357, 2300718. https:\/\/doi.org\/10.1002\/ardp.202300718 (2024).","journal-title":"Arch. Pharm."},{"key":"91113_CR26","doi-asserted-by":"publisher","first-page":"116434","DOI":"10.1016\/j.ejmech.2024.116434","volume":"271","author":"MA Gamal","year":"2024","unstructured":"Gamal, M. A. et al. Probing benzenesulfonamide\u2013thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: \u03b1-glucosidase and carbonic anhydrase II. Eur. J. Med. Chem. 271, 116434. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116434 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"91113_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2174\/157340608784872280","volume":"4","author":"SE Harpstrite","year":"2008","unstructured":"Harpstrite, S. E., Collins, S. D., Oksman, A., Goldberg, D. E. & Sharma, V. Synthesis, characterization, and antimalarial activity of novel schiff-base-phenol and naphthalene-amine ligands. Med. Chem. 4, 392\u2013395. https:\/\/doi.org\/10.2174\/157340608784872280 (2008).","journal-title":"Med. Chem."},{"key":"91113_CR28","doi-asserted-by":"publisher","first-page":"138148","DOI":"10.1016\/j.molstruc.2024.138148","volume":"1309","author":"MA Shaldam","year":"2024","unstructured":"Shaldam, M. A. et al. Novel sulfonamide-tethered schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: synthesis, biological assessment, and molecular dynamic simulations. J. Mol. Struct. 1309, 138148. https:\/\/doi.org\/10.1016\/j.molstruc.2024.138148 (2024).","journal-title":"J. Mol. Struct."},{"key":"91113_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.bmcl.2014.11.088","volume":"25","author":"AM Alafeefy","year":"2015","unstructured":"Alafeefy, A. M. et al. Synthesis, analgesic, anti-inflammatory, and anti-ulcerogenic activities of certain novel Schiff\u2019s bases as Fenamate isosteres. Bioorg. Med. Chem. Lett. 25, 179\u2013183. https:\/\/doi.org\/10.1016\/j.bmcl.2014.11.088 (2015).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"91113_CR30","doi-asserted-by":"publisher","first-page":"136318","DOI":"10.1016\/j.molstruc.2023.136318","volume":"1293","author":"A \u00dcnl\u00fc","year":"2023","unstructured":"\u00dcnl\u00fc, A. et al. Biological evaluation of schiff bases containing dopamine as antibacterial\/antifungal and potential anti COVID-19 agents: design, synthesis, characterization, molecular Docking studies, and ADME properties. J. Mol. Struct. 1293, 136318. https:\/\/doi.org\/10.1016\/j.molstruc.2023.136318 (2023).","journal-title":"J. Mol. Struct."},{"key":"91113_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/antibiotics13050423","volume":"13","author":"J Ceramella","year":"2024","unstructured":"Ceramella, J. et al. A review on the antimicrobial activity of schiff bases: data collection and recent studies. Antibiotics 13, 423. https:\/\/doi.org\/10.3390\/antibiotics13050423 (2024).","journal-title":"Antibiotics"},{"key":"91113_CR32","doi-asserted-by":"publisher","first-page":"6531","DOI":"10.1007\/s11164-016-2478-y","volume":"42","author":"NO Mahmoodi","year":"2016","unstructured":"Mahmoodi, N. O., Khalili, B., Rezaeianzadeh, O. & Ghavidast, A. One-pot multicomponent synthesis of indol-3-yl-hydrazinyl thiazoles as antimicrobial agents. Res. Chem. Intermed. 42, 6531\u20136542. https:\/\/doi.org\/10.1007\/s11164-016-2478-y (2016).","journal-title":"Res. Chem. Intermed"},{"key":"91113_CR33","doi-asserted-by":"publisher","first-page":"125220","DOI":"10.1016\/j.matchemphys.2021.125220","volume":"275","author":"V Sriraman","year":"2022","unstructured":"Sriraman, V. et al. Synthesis, crystal structure, DFT, docking, and biological activity studies of (NZ,N\u2019Z)-3,3\u2019-(piperazine-1,4-diyl)bis(N-(-4-methyl benzylidene) propane-1-amine. Mater. Chem. Phys. 275, 125220. https:\/\/doi.org\/10.1016\/j.matchemphys.2021.125220 (2022).","journal-title":"Mater. Chem. Phys."},{"key":"91113_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ejmech.2012.04.009","volume":"53","author":"MM Ghorab","year":"2012","unstructured":"Ghorab, M. M. et al. Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety. Eur. J. Med. Chem. 53, 403\u2013407. https:\/\/doi.org\/10.1016\/j.ejmech.2012.04.009 (2012).","journal-title":"Eur. J. Med. Chem."},{"key":"91113_CR35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ejmech.2017.07.073","volume":"139","author":"WM Eldehna","year":"2017","unstructured":"Eldehna, W. M. et al. Novel 4\/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: synthesis, carbonic anhydrase inhibitory activity, anticancer activity, and molecular modeling studies. Eur. J. Med. Chem. 139, 250\u2013262. https:\/\/doi.org\/10.1016\/j.ejmech.2017.07.073 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"91113_CR36","doi-asserted-by":"publisher","first-page":"106309","DOI":"10.1016\/j.bioorg.2022.106309","volume":"131","author":"A El-Malah","year":"2023","unstructured":"El-Malah, A. et al. Schiff bases as linker in the development of quinoline-sulfonamide hybrids as selective cancer-associated carbonic anhydrase isoforms IX\/XII inhibitors: A new regio-isomerism tactic. Bioinorg. Chem. 131, 106309. https:\/\/doi.org\/10.1016\/j.bioorg.2022.106309 (2023).","journal-title":"Bioinorg. Chem."},{"key":"91113_CR37","doi-asserted-by":"publisher","unstructured":"Senol, H., Agg\u00fcl, A. G., Atasoy, S. & G\u00fczeldemirci, N. Synthesis, characterization, molecular docking and in vitro anti-cancer activity studies of new and highly selective 1,2,3-triazole substituted 4-hydroxybenzohyrdazide derivatives. J. Mol. Struct. 1283, 135247. (2023). https:\/\/doi.org\/10.1016\/j.molstruc. 135247 (2023).","DOI":"10.1016\/j.molstruc"},{"key":"91113_CR38","doi-asserted-by":"publisher","first-page":"e202300481","DOI":"10.1002\/slct.202300481","volume":"8","author":"H Senol","year":"2023","unstructured":"Senol, H., Agg\u00fcl, A. G., Atasoy, S. & Synthesis Characterization, molecular Docking and in vitro biological studies of Thiazolidin-4-one derivatives as Anti-Breast-Cancer agents. ChemistrySelect 8, e202300481. https:\/\/doi.org\/10.1002\/slct.202300481 (2023).","journal-title":"ChemistrySelect"},{"key":"91113_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.procbio.2023.11.029","volume":"136","author":"\u00d6 Demirk\u0131ran","year":"2024","unstructured":"Demirk\u0131ran, \u00d6. et al. Cytotoxic meroterpenoids from brown Alga Stypopodium schimperi (K\u00fctzing) verlaque & Boudouresque with comprehensive molecular Docking & dynamics and ADME studies. Process. Biochem. 136, 90\u2013108. https:\/\/doi.org\/10.1016\/j.procbio.2023.11.029 (2024).","journal-title":"Process. Biochem."},{"key":"91113_CR40","doi-asserted-by":"publisher","first-page":"135176","DOI":"10.1016\/j.molstruc.2023.135176","volume":"1282","author":"FS Tokali","year":"2023","unstructured":"Tokali, F. S., Senol, H., Bulut, S. & Haciosmanoglu-Aldogan, E. Synthesis, characterization and molecular Docking studies of highly selective new hydrazone derivatives of anthranilic acid and their ring closure analog Quinazolin-4(3H)-ones against lung cancer cells A549. J. Mol. Struct. 1282, 135176. https:\/\/doi.org\/10.1016\/j.molstruc.2023.135176 (2023).","journal-title":"J. Mol. Struct."},{"key":"91113_CR41","doi-asserted-by":"publisher","first-page":"13121","DOI":"10.1016\/j.molstruc.2021.131212","volume":"1246","author":"U Vanitha","year":"2021","unstructured":"Vanitha, U., Elancheran, R., Manikandan, V., Kabilan, S. & Krishnasamy, K. Design, synthesis, characterization, molecular Docking and computational studies of 3-phenyl-2-thioxoimidazolidin-4-one derivatives. J. Mol. Struct. 1246, 13121. https:\/\/doi.org\/10.1016\/j.molstruc.2021.131212 (2021).","journal-title":"J. Mol. Struct."},{"key":"91113_CR42","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jcc.20290","volume":"26","author":"DA Case","year":"2005","unstructured":"Case, D. A. et al. The amber biomolecular simulation programs. J. Comput. Chem. 26, 1668\u20131688. https:\/\/doi.org\/10.1002\/jcc.20290 (2005).","journal-title":"J. Comput. Chem."},{"key":"91113_CR43","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3390\/biomedicines9040357","volume":"9","author":"SM Marques","year":"2021","unstructured":"Marques, S. M. et al. Screening of natural compounds as P-glycoprotein inhibitors against multidrug resistance. Biomedicines 9, 357. https:\/\/doi.org\/10.3390\/biomedicines9040357 (2021).","journal-title":"Biomedicines"},{"key":"91113_CR44","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann, U. et al. A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577\u20138593. https:\/\/doi.org\/10.1063\/1.470117 (1995).","journal-title":"J. Chem. Phys."},{"key":"91113_CR45","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/jcc.540130805","volume":"13","author":"S Miyamoto","year":"1992","unstructured":"Miyamoto, S., Kollman, P. A. & Settle An analytical version of the SHAKE and RATTLE algorithm for rigid water models. J. Comput. Chem. 13, 952\u2013962. https:\/\/doi.org\/10.1002\/jcc.540130805 (1992).","journal-title":"J. Comput. Chem."},{"key":"91113_CR46","doi-asserted-by":"publisher","first-page":"736509","DOI":"10.3389\/fchem.2021.736509","volume":"9","author":"S Shityakov","year":"2021","unstructured":"Shityakov, S. et al. Scaffold searching of FDA and EMA-approved drugs identifies lead candidates for drug repurposing in Alzheimer\u2019s disease. Front. Chem. 9, 736509. https:\/\/doi.org\/10.3389\/fchem.2021.736509 (2021).","journal-title":"Front. Chem."},{"key":"91113_CR47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s40203-024-00288-z","volume":"13","author":"H Khalid","year":"2025","unstructured":"Khalid, H. & Shityakov, S. Immunoinformatics-driven design and computational analysis of a multiepitope vaccine targeting uropathogenic Escherichia coli. Silico Pharmacol. 13, 2. https:\/\/doi.org\/10.1007\/s40203-024-00288-z (2025).","journal-title":"Silico Pharmacol."},{"key":"91113_CR48","doi-asserted-by":"publisher","first-page":"130805","DOI":"10.1016\/j.molstruc.2021.130805","volume":"1242","author":"S Anitha","year":"2021","unstructured":"Anitha, S., Krishnan, S., Senthilkumar, K. & Sasirekha, V. A comparative investigation on the scavenging of 2,2-diphenyl-1-picrylhydrazyl radical by the natural antioxidants (+) Catechin and (-) epicatechin. J. Mol. Struct. 1242, 130805. https:\/\/doi.org\/10.1016\/j.molstruc.2021.130805 (2021).","journal-title":"J. Mol. Struct."},{"key":"91113_CR49","doi-asserted-by":"publisher","first-page":"28475","DOI":"10.1038\/s41598-024-77980-9","volume":"14","author":"C He","year":"2024","unstructured":"He, C. et al. Down-regulation of ESRP2 inhibits breast cancer cell proliferation via inhibiting cyclinD1. Sci. Rep. 14, 28475. https:\/\/doi.org\/10.1038\/s41598-024-77980-9 (2024).","journal-title":"Sci. Rep."},{"key":"91113_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jphotobiol.2017.05.020","volume":"172","author":"CM da Silva","year":"2017","unstructured":"da Silva, C. M. et al. Studies on free radical scavenging, cancer cell antiproliferation, and calf thymus DNA interaction of schiff bases. J. Photochem. Photobiol B. 172, 129\u2013138. https:\/\/doi.org\/10.1016\/j.jphotobiol.2017.05.020 (2017).","journal-title":"J. Photochem. Photobiol B"},{"key":"91113_CR51","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.3c07216","author":"M Ayaz","year":"2023","unstructured":"Ayaz, M. et al. Biooriented synthesis of Ibuprofen-Clubbed novel Bis-Schiff base derivatives as potential hits for malignant glioma: in vitro anticancer activity and in Silico approach. ACS Omega. https:\/\/doi.org\/10.1021\/acsomega.3c07216 (2023). 49228\u2009\u2013\u200949243.","journal-title":"ACS Omega"},{"key":"91113_CR52","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.arabjc.2017.05.004","volume":"13","author":"H Kaur","year":"2020","unstructured":"Kaur, H. et al. Diazenyl schiff bases: synthesis, spectral analysis, antimicrobial studies, and cytotoxic activity on human colorectal carcinoma cell line (HCT-116). Arab. J. Chem. 13, 377\u2013392. https:\/\/doi.org\/10.1016\/j.arabjc.2017.05.004 (2020).","journal-title":"Arab. J. Chem."},{"key":"91113_CR53","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.bmcl.2010.03.039","volume":"20","author":"LX Cheng","year":"2010","unstructured":"Cheng, L. X. Antioxidant and antiproliferative activities of hydroxyl-substituted schiff bases. Bioorg. Med. Chem. Lett. 20, 2417\u20132420. https:\/\/doi.org\/10.1016\/j.bmcl.2010.03.039 (2010).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"91113_CR54","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bioorg.2018.10.046","volume":"82","author":"K Kanwal","year":"2019","unstructured":"Kanwal, K. et al. Schiff bases of tryptamine as potent inhibitors of nucleoside triphosphate diphosphohydrolases (NTPDases): Structure-activity relationship. Bioorg. Chem. 82, 253\u2013266. https:\/\/doi.org\/10.1016\/j.bioorg.2018.10.046 (2019).","journal-title":"Bioorg. Chem."},{"key":"91113_CR55","doi-asserted-by":"publisher","first-page":"112262","DOI":"10.1016\/j.molliq.2019.112262","volume":"300","author":"S Shokrollahi","year":"2020","unstructured":"Shokrollahi, S., Amiri, A., Fadaei-Tirani, F. & Schenk, K. Promising anti-cancer potency of 4,5,6,7-tetrahydrobenzo[d]thiazole-based Schiff-bases. J. Mol. Liq. 300, 112262. https:\/\/doi.org\/10.1016\/j.molliq.2019.112262 (2020).","journal-title":"J. Mol. Liq"},{"key":"91113_CR56","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.biopha.2017.01.108","volume":"89","author":"S Chacko","year":"2017","unstructured":"Chacko, S. & Samanta, S. A novel approach towards design, synthesis, and evaluation of some schiff base analogs of 2-aminopyridine and 2-aminobezothiazole against hepatocellular carcinoma. Biomed. Pharmacother. 89, 162\u2013176. https:\/\/doi.org\/10.1016\/j.biopha.2017.01.108 (2017).","journal-title":"Biomed. Pharmacother"},{"key":"91113_CR57","doi-asserted-by":"publisher","first-page":"134623","DOI":"10.1016\/j.molstruc.2022.134623","volume":"1275","author":"Y Belay","year":"2023","unstructured":"Belay, Y. et al. Synthesis, antibacterial activities, cytotoxicity, and molecular Docking studies of salicyledene derivatives. J. Mol. Struct. 1275, 134623. https:\/\/doi.org\/10.1016\/j.molstruc.2022.134623 (2023).","journal-title":"J. Mol. Struct."},{"key":"91113_CR58","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/molecules27030835","volume":"27","author":"AA Abu-Hashem","year":"2022","unstructured":"Abu-Hashem, A. A., Al-Hussain, S. A. & Design Synthesis of new 1,2,4-Triazole\/1,3,4-Thiadiazole with spiroindoline, Imidazo[4,5-b]quinoxaline and Thieno[2,3-d]pyrimidine from Isatin derivatives as anticancer agents. Mol 27, 835. https:\/\/doi.org\/10.3390\/molecules27030835 (2022).","journal-title":"Mol"},{"key":"91113_CR59","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, druglikeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717. https:\/\/doi.org\/10.1038\/srep42717 (2017).","journal-title":"Sci. Rep."},{"key":"91113_CR60","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/1811199a0","volume":"181","author":"MS Blois","year":"1985","unstructured":"Blois, M. S. Antioxidant determinations by the use of a stable free radical. Nature 181, 1199\u20131200. https:\/\/doi.org\/10.1038\/1811199a0 (1985).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91113-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91113-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91113-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T16:36:20Z","timestamp":1740414980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91113-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91113"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91113-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6661"}}